title: Increased peripheral RORα and RORγt mRNA expression is associated with acute-on-chronic hepatitis B liver failure.
abstract: T helper cells17 (Th17) have accurate but inconclusive roles in the pathogenesis of acute-on-chronic hepatitis B liver failure (ACHBLF). Retinoic acid-related orphan receptor γ t(RORγt) and RORα are two lineage-specific nuclear receptors directly mediating Th17 differentiation. This study was aimed to evaluate the gene expression of RORα and RORγt and their potential role in ACHBLF. Forty patients with liver failure, 30 with chronic hepatitis B (CHB) and 20 healthy controls were studied. The mRNA levels of RORα and RORγt in peripheral mononuclear cells were determined by quantitative real-time polymerase chain reaction. The frequency of peripheral Th17 cells was determined using flow cytometry. The serum levels of interleukin-6(IL-6), transforming growth factor -β (TGF-β), interleukin-17(IL-17), interleukin-23(IL-23) and interferon-γ (IFN-γ) were measured by enzyme-linked immunosorbent assay. The frequency of peripheral Th17 cells in patients with liver failure was significantly increased compared to patients with CHB and controls. The peripheral mRNA levels of RORα and RORγt in hepatitis B-associated acute-on-chronic liver failure were significantly higher than in patients with CHB and controls as were the serum levels of IL-6 and TGF-β. The serum level of IFN-γ in patients with acute-on-chronic liver failure from HBV was significantly higher than patients with CHB but lower than controls. In patients with acute-on-chronic liver failure associated with HBV, RORγt, IL-6 and IL-23 were positively correlated with the frequency of Th17 cells, while RORα, TGF-β and IFN-γ had no correlation with the latter. The mRNA level of RORγt was positively correlated with model of end-stage liver disease (MELD) score, but there was no correlation of RORα and MELD score. RORγt plays an important role in the pathogenesis of acute-on-chronic HBV-associated liver failure and might be considered to be a candidate factor consistent with the severity of disease.
authors.affiliation: Department of Hepatology, Qilu Hospital of Shandong University, Jinan, China.
authors.forename: Z-X
authors.initials: ZX
authors.lastname: Qi
authors.forename: L-Y
authors.initials: LY
authors.lastname: Wang
authors.forename: Y-C
authors.initials: YC
authors.lastname: Fan
authors.forename: J-J
authors.initials: JJ
authors.lastname: Zhang
authors.forename: T
authors.initials: T
authors.lastname: Li
authors.forename: K
authors.initials: K
authors.lastname: Wang
mesh_terms: D000328:Adult; D005260:Female; D019694:Hepatitis B, Chronic / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007371:Interferon-gamma / Q000097:blood; D020381:Interleukin-17 / Q000097:blood; D053759:Interleukin-23 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D017114:Liver Failure, Acute / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D018655:Lymphocyte Count; D008297:Male; D057094:Nuclear Receptor Subfamily 1, Group F, Member 1 / Q000096:biosynthesis / Q000235:genetics*; D057132:Nuclear Receptor Subfamily 1, Group F, Member 3 / Q000096:biosynthesis / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012720:Severity of Illness Index; D058504:Th17 Cells / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000097:blood
chemical_list: D020381:Interleukin-17; D053759:Interleukin-23; D015850:Interleukin-6; D057094:Nuclear Receptor Subfamily 1, Group F, Member 1; D057132:Nuclear Receptor Subfamily 1, Group F, Member 3; D012333:RNA, Messenger; C539738:RORA protein, human; C539900:RORC protein, human; D016212:Transforming Growth Factor beta; D007371:Interferon-gamma